SPY753.68+0.13%QQQ680.59+0.18%BTC/USD75,013.40−0.32%DIA523.71+0.07%GLD378.70−0.22%TLT81.80−0.19%

Premium Services

Alvotech

ALVONASDAQ

Trade with Public

Trade with Public

$4.69

-0.17-3.5%

Last update: Nov 9, 6:00 PM

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Compare Stock Report

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2026 Benzinga | All Rights Reserved

Alvotech (ALVO) Stock Price Target 2026

The average analyst price target for Alvotech is $10.71, 128.4% above the current price. Of 6 analysts, 5 rate it Buy and 1 Hold. Targets range from $6 to $18. The latest change came on Sep 16, 2026, when Barclays upgraded Alvotech from Underweight to Overweight and moved its price target from $4 to $8.

The Average Analyst Price Target for Alvotech is $10.71.

Price Target Range — 8 Quarters

Analyst Consensus — 6 Analysts

5Buy

1Hold

Consensus RatingBuy# Analysts6Avg. Consensus PT$10.71Upside to Avg. PT+128.4%

Rating Trend — Last 9 Months

Latest Upgrades and Downgrades for Alvotech Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 16, 2026	Barclays	Glen Santangelo	Upgrade	Underweight→Overweight	$4→$8
Aug 24, 2026	B of A Securities	Jason Gerberry	Initiate	Buy	$7
Aug 14, 2026	Evercore ISI Group	Umer Raffat	Initiate	Outperform	—
Mar 24, 2026	UBS	Ashwani Verma	PT Cut	Buy	$10→$6
Mar 24, 2026	Barclays	Glen Santangelo	PT Cut	Underweight	$5→$4
Dec 9, 2025	Barclays	Glen Santangelo	Initiate	Underweight	$5
Nov 18, 2025	UBS	Ashwani Verma	PT Cut	Buy	$13→$10
Nov 4, 2025	Deutsche Bank	Niall Alexander	Downgrade	Buy→Hold	$14→$8
Oct 14, 2025	Morgan Stanley	Thibault Boutherin	Upgrade	Equal-Weight→Overweight	$14
Sep 23, 2025	Deutsche Bank	Niall Alexander	Upgrade	Hold→Buy	$14
Jul 18, 2025	UBS	—	PT Cut	Buy	$16→$14
Feb 14, 2025	UBS	—	Initiate	Buy	$18
Jul 25, 2024	Barclays	Balaji Prasad	PT Cut	Overweight	$22→$18
May 24, 2024	Barclays	Balaji Prasad	PT Raise	Overweight	$20→$22
Mar 22, 2024	Barclays	Balaji Prasad	PT Raise	Overweight	$17→$20
Jan 29, 2024	Barclays	Balaji Prasad	Upgrade	Equal-Weight→Overweight	$10→$17

Analyst Ratings News

Rapport Therapeutics To Rally Around 76%? Here Are 10 Top Analyst Forecasts For Wednesday

Analysts raised targets for RAPP, ALLR, UNP and ALVO; cut targets for NU, CLLS and JBHT, with several rating upgrades and downgrades.

Avi Kapoor

This Union Pacific Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday

Analysts upgraded Similarweb, Rocket Pharmaceuticals, Radiant Logistics and Ulta Beauty; Paychex rose to Peer Perform, with targets raised.

Avi Kapoor

PRO
Barclays Upgrades Alvotech to Overweight, Raises Price Target to $8

Barclays analyst Glen Santangelo upgrades Alvotech (NASDAQ:ALVO) from Underweight to Overweight and raises the price target from $4 to $8.

Benzinga Newsdesk

PRO
B of A Securities Initiates Coverage On Alvotech with Buy Rating, Announces Price Target of $7

B of A Securities analyst Jason Gerberry initiates coverage on Alvotech (NASDAQ:ALVO) with a Buy rating and announces Price Target of $7.

Benzinga Newsdesk

PRO
Evercore ISI Group Initiates Coverage On Alvotech with Outperform Rating

Evercore ISI Group analyst Umer Raffat initiates coverage on Alvotech (NASDAQ:ALVO) with a Outperform rating.

Benzinga Newsdesk

PRO
UBS Maintains Buy on Alvotech, Lowers Price Target to $6

UBS analyst Ashwani Verma maintains Alvotech (NASDAQ:ALVO) with a Buy and lowers the price target from $10 to $6.

Benzinga Newsdesk